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Abstract The stromal vascular fraction (SVF) of adipose
tissue contains an abundant population of multipotent
adipose-tissue-derived stem cells (ASCs) that possess the
capacity to differentiate into cells of the mesodermal lineage
in vitro. For cell-based therapies, an advantageous approach
would be to harvest these SVF cells and give them back to
the patient within a single surgical procedure, thereby
avoiding lengthy and costly in vitro culturing steps.
However, this requires SVF-isolates to contain sufficient
ASCs capable of differentiating into the desired cell lineage.
We have investigated whether the yield and function of
ASCs are affected by the anatomical sites most frequently
used for harvesting adipose tissue: the abdomen and hip/
thigh region. The frequency of ASCs in the SVF of adipose
tissue from the abdomen and hip/thigh region was deter-
mined in limiting dilution and colony-forming unit (CFU)
assays. The capacity of these ASCs to differentiate into the
chondrogenic and osteogenic pathways was investigated by
quantitative real-time polymerase chain reaction and
(immuno)histochemistry. A significant difference (P=0.0009)
was seen in ASC frequency but not in the absolute number of
nucleated cells between adipose tissue harvested from the
abdomen (5.1±1.1%, mean±SEM) and hip/thigh region
(1.2±0.7%). However, within the CFUs derived from both
tissues, the frequency of CFUs having osteogenic differenti-
ation potential was the same. When cultured, homogeneous
cell populations were obtained with similar growth kinetics
and phenotype. No differences were detected in differentia-
tion capacity between ASCs from both tissue-harvesting sites.
We conclude that the yield of ASCs, but not the total amount
of nucleated cells per volume or the ASC proliferation and
differentiation capacities, are dependent on the tissue-
harvesting site. The abdomen seems to be preferable to the
hip/thigh region for harvesting adipose tissue, in particular
when considering SVF cells for stem-cell-based therapies in
one-step surgical procedures for skeletal tissue engineering.
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Introduction
Tissue engineering is an emerging field in modern medicine.
Therapies involve the combination of cells and scaffold
materials that can be loaded with bioactive factors, ideally
resulting in the regeneration or replacement of lost or
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Amsterdam, The Netherlandsdamaged tissues and organs. Multiple cell sources have been
investigated for their possible applicability in tissue engineer-
ing. Embryonal stem cells are the most potent stem cells;
however, their use is controversial and has mayor ethical
considerations (Dresser 2001). Mesenchymal stem cells
(MSCs) can be obtained from the adult and are widely used
because of their differentiation potential. In addition to bone
marrow, periosteum (Nakahara et al. 1991), muscle (Asakura
et al. 2001), and adipose tissue (Zuk et al. 2002) also appear
to be sources of MSCs.
Subcutaneous adipose tissue is a particularly attractive
reservoir of progenitor cells, because it is easily accessible,
abundant, and self-replenishing. It is derived from the
mesodermal germ layer and contains a supportive stromal
vascular fraction (SVF) that can be readily isolated
(Gronthos et al. 2003; Zuk et al. 2001). This SVF from
adipose tissue consists of a heterogeneous mixture of cells,
including endothelial cells, smooth muscle cells, pericytes,
leukocytes, mast cells, and pre-adipocytes (Oedayrajsingh-
Varma et al. 2006; Peterson et al. 2005; Prunet-Marcassus
et al. 2005). In addition to these cells, the SVF contains an
abundant population of multipotent adipose-tissue-derived
stem cells (ASCs) that possess the capacity to differentiate
into cells of mesodermal origin in vitro, e.g., adipocytes,
chondrocytes, osteoblasts, and (cardio)myocytes (Erickson
et al. 2002; Guilak et al. 2004; Halvorsen et al. 2001;
Hattori et al. 2004; Planat-Benard et al. 2004; Rangappa et
al. 2003; Zuk et al. 2001). Because of these favorable
characteristics, interest has been growing in the application
of ASCs for cell-based therapies such as tissue engineering.
For clinical practice, an advantageous approach would
be to harvest ASCs and immediately give them back to the
patient within the same operation, the so called “one-step
surgical procedure” (Helder et al. 2007). This overcomes
long-lasting culture expansion of ASCs on the one hand,
but necessitates the use of the SVF of adipose tissue on the
other hand, since fast selection procedures for stem cells in
the SVF are not yet available. Therefore, the success of this
procedure requires SVF-isolates to contain sufficient ASCs
capable of differentiating into the desired cell lineage. In
view of this, we have previously investigated the effect of
three different surgical procedures for the harvesting of
adipose tissue, i.e., resection, tumescent or conventional
liposuction, and ultrasound-assisted liposuction, on the
yield and function of the stem cells. We have demonstrated
that the SVF isolates from adipose tissue harvested by
ultrasound-assisted liposuction contain fewer stem cells,
and that the stem cells have a longer population doubling
time, leading us to conclude that resection and tumescent
liposuction are preferable to ultrasound-assisted liposuction
for harvesting adipose tissue, if the cells are to be used for
tissue-engineering purposes (Oedayrajsingh-Varma et al.
2006).
In the present study, we have investigated whether
the yield and functional characteristics of ASCs in the
SVF are affected by the most frequently used adipose-
tissue-harvesting sites. We have previously demonstrated
that the yield of nucleated cells in the SVF of the adipose
tissue from these different tissue-harvesting sites is similar
(Oedayrajsingh-Varma et al. 2006). In the current study,
the frequency of ASCs in the SVF cell isolates has been
determined by using limiting dilution and colony-forming
unit (CFU) assays. In addition, we have investigated the
frequency of CFUs showing an osteogenic differentiation
capacity. SVF cells have been subsequently cultured in
order to obtain homogeneous cell populations and to
acquire sufficient cells to determine their chondrogenic
differentiation potential in micromass cultures. Homoge-
neity has been checked by determining the growth kinetics
and phenotypic characteristics of the ASCs. To verify the
maintenance of multidifferentiation potential, osteogenic
and chondrogenic induction has been assessed in these
homogeneous ASC cultures.
Materials and methods
Donors
Samples of human subcutaneous adipose tissue were
obtained as waste material after elective tumescent liposuc-
tion or resection and donated after informed consent from
healthy donors operated on at the Departments of Plastic
Surgery of two clinics in Amsterdam, The Netherlands.
Adipose tissue was taken from the abdomen (n=12) and the
hip/thigh region (n=10) during cosmetic surgery; 22 female
donors were included in this study. The average age (mean
age 40, range 24–62 years) and body mass index (BMI;
mean BMI 25.5; range 22.2–29.6 kg/m
2) were similar for
both groups (Table 1).
Cell isolation and storage
Isolation of the SVF from adipose tissue was performed as
previously described (Oedayrajsingh-Varma et al. 2006). The
isolation protocol included a Ficoll density centrifugation
step to remove contaminating erythrocytes. After isolation,
4×10
6 SVF cells were resuspended in a mixture (1:1) of
Dulbecco’s modified Eagle’s medium (DMEM) and cryo-
protective medium (Freezing Medium, BioWhittaker, Cam-
brex, Verviers, Belgium), frozen under “controlled rate”
conditions in a Kryosave (HCI Cryogenics, Hedel, The
Netherlands), and stored in the vapor phase of liquid nitrogen
according to standard practice at the Department of Pathol-
ogy of the VU University Medical Center and following the
guidelines of current Good Manufacturing Practice.
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To assess the frequency of ASCs in the SVF of adipose
tissue, SVF cells were seeded in normal culture medium,
consisting of DMEM supplemented with 10% fetal bovine
serum (FBS), 100 U/ml penicillin, 100 μg/ml streptomycin,
and 2 mM L-glutamine (Invitrogen, Gibco, Calif., USA) in
96-well plates at 15×10
3 cells/well in the upper row. Two-
fold dilution steps of the cells were made in subsequent
rows. All cultures were performed in duplicate. Medium
was changed twice a week. After 3 weeks, each well was
individually scored for the number of cells. A well
containing a cluster of at least 10 adhered fibroblast-like
cells was considered as being positive. The frequency of
ASCs was calculated from the rows of cells for which
25%–75% of the wells were scored as positive.
CFU assays
CFU assays were performed to check the consistency of the
limiting dilution assay method and to determine the
frequency of CFU capable of differentiating into the
osteogenic lineage from the abdomen (n=7) and hip/thigh
region (n=6). SVF cells were resuspended in normal culture
medium, consisting of DMEM supplemented with 10%
FBS, 100 U/ml penicillin, 100 μg/ml streptomycin, and
2 mM L-glutamine (Invitrogen, Gibco). Two 6-well plates
were prepared in which the SVF was diluted ten-fold across
both columns, resulting in a upper column containing 10
4
and a lower column containing 10
3 nucleated SVF cells.
For the CFU-fibroblast (CFU-F) assay, the fixation time
was 11–14 days, depending on the amount and growth
kinetics of the colonies (merging of colonies was avoided).
At the appropriate time point, the medium was removed,
and the cells were washed with phosphate-buffered saline
(PBS), fixed with 4% formaldehyde for 10 min, and
subsequently colored in a 0.2% toluidine blue solution in
borax buffer for about 1 min. Excess stain was washed off
with distilled water, and colonies were counted.
Cells of the duplicate 6-well plate were submitted to a
CFU-alkaline phosphatase (CFU-ALP) assay. Cultures
were performed in normal medium for 7 days in order to
obtain colonies and to remove contaminating cells, after
which osteogenic medium was added for 2 weeks. Follow-
ing this period, cells in the CFU-ALP plate were rinsed
with PBS, fixed in 4% formaldehyde, and incubated for
10 min in a 0.2 M TRIS-hydrochloride (pH 10), 0.2 M
calcium chloride, 0.1 M magnesium chloride solution,
whereafter a solution containing 0.2 M TRIS-hydrochloride
(pH 10), 0.2 M calcium chloride, 0.1 M magnesium chloride,
and 600 μl nitroblue tetrazolium/5-bromo-4-chloro-3-
indolyl-phosphate was added for 30 min. The percentage of
the colonies staining positive for ALP was determined.
Table 1 Population characteristics (BMI body mass index, THS tissue-harvesting site, ASC adipose-derived stem cell, Res resection, T-LS
tumescent liposuction, ND not determined)
Donor Age (years) BMI (kg/m
2) THS Procedure ASC yield (%)
1 02-0001 62 22.6 Abdomen Res 9.20
2 03-0007 26 24.4 Abdomen T-LS 8.50
3 03-0018 42 23.9 Abdomen Res 12.50
4 03-0021 57 29.6 Abdomen Res 4.40
5 04-0003 37 ND Abdomen T-LS 2.20
6 04-0013 36 28.1 Abdomen Res 2.20
7 04-0015 37 26.9 Abdomen Res 0.93
8 05-0004 39 ND Abdomen T-LS 1.50
9 05-0007 42 28.3 Abdomen T-LS 8.30
10 06-0003 50 26.5 Abdomen T-LS 3.6
11 06-0006 42 24.2 Abdomen T-LS 4.8
12 06-0007 46 30.5 Abdomen T-LS 9.7
13 03-0010 24 24.4 Hip/thigh T-LS 0.30
14 04-0004 40 ND Hip/thigh T-LS 0.82
15 04-0008 27 26.6 Hip/thigh T-LS 0.16
16 04-0009 36 ND Hip/thigh T-LS 0.16
17 05-0005 34 22.2 Hip/thigh T-LS 0.60
18 05-0006 28 23.2 Hip/thigh T-LS 0.21
19 05-0008 43 24.6 Hip/thigh T-LS 7.20
20 06-0005 33 23.2 Hip/thigh T-LS 0.10
21 06-0010 52 26.2 Hip/thigh T-LS 2.70
22 06-0012 42 23.7 Hip/thigh T-LS 0.16
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ASCs from the abdomen and hip/thigh region were cultured
up to passage 2 for an adequate and quantitative compar-
ison of stem-cell proliferation and differentiation capacity.
Single-cell suspensions of cryopreserved SVF cells were
seeded at 5.0×10
6 nucleated cells/cm
2 in normal culture
medium. The cultures were maintained in a 5% CO2
incubator at 37°C in a humidified atmosphere. The medium
was changed twice a week. When reaching 80%–90%
confluency, cells were detached with 0.5 mM EDTA/0.05%
trypsin (Invitrogen) for 5 min at 37°C and replated. Cell
viability was assessed by using the trypan blue exclusion
assay. A homogeneous population of ASCs was thus
obtained from abdomen and hip/thigh region and was
subsequently checked by determining growth kinetics and
by analyzing the surface-marker expression profile of the
ASCs.
Growth kinetics of ASCs
To determine the growth kinetics of cultured ASCs, ten T25
flasks per donor were seeded with 1×10
5 cultured ASCs
(passage 2 or 3). At several time points (between days 2
and 12) after seeding, cells from two duplicate flasks were
harvested and counted. ASC numbers were plotted against
the number of days cultured, and the exponential growing
phase of the cells was determined. The population doubling
time was calculated by using the formula:
Population Doubling Time ¼
Days in exponential phase
log N2   log N1 ðÞ =log 2
where N1 was the number of cells at the beginning of the
exponential growing phase, and N2 was the number of cells
at the end of the exponential growing phase.
Flow cytometry
Single-cell suspensions of cultured ASCs from abdomen and
hip/thigh region were phenotypically characterized by using
fluorescence-activated cell sorting (FACS; FACSCalibur,
Becton Dickinson, USA) as previously described (Varma
et al. 2007). All monoclonal antibodies (mAbs) were of the
immunoglobulin G1 (IgG1) isotype. Cells were stained with
fluorescently labeled antibodies (conjugated to fluorescein
isothiocyanate, phycoerythrin, or allophycocyanin) against
CD31, CD34, CD45, CD54, CD90, CD106, HLA-DR, and
HLA-ABC (BD Biosciences, San José, Calif.), CD166 (RDI
Research Diagnostics, Flanders, N.J.), CD105 (Caltag
Laboratories, Burlingame, Calif.), CD117 (PharMingen,
San Diego, Calif.), and CD146 (Chemicon, Temecula,
Calif.). Nonspecific fluorescence was determined by incu-
bating the cells with conjugated mAb anti-human IgG1
(DakoCytomation, Glostrup, Denmark).
Chondrogenic and osteogenic differentiation
The chondrogenic and osteogenic differentiation capacities
of the cultured ASCs from the abdomen (n=4) and hip/
thigh region (n=4) were studied. Chondrogenic differenti-
ation was induced in cultured ASCs as previously
described, with some modifications (Oedayrajsingh-Varma
et al. 2006). In short, a 50-μl drop of a concentrated ASC
cell suspension (8×10
6cells/ml, passage 2) was applied to a
glass slide and allowed to attach at 37°C for 1 h. Then,
750 μl chondrogenic medium, consisting of DMEM, plus
ITS+ Premix (final concentration in medium when diluted
1:100 was 6.25 μg/ml insulin, 6.25 μg/ml transferrin,
6.25 ng/ml selenous acid, 1.25 mg/ml bovine serum
albumin (BSA), 5.35 μg/ml linoleic acid; BD, USA),
10 ng/nl transforming growth factor- β1 (TGF-β1; Bio-
vision, ITK-diagnostics), 1% FCS, 25 μMa s c o r b a t e -
2-phosphate (Sigma, St. Louis, Mo.), 100 U/ml penicillin,
100 μg/ml streptomycin, and 2 mM L-glutamine, was
overlaid gently. Cells were maintained in a 5% CO2/1%
oxygen custom-designed hypoxia workstation (T.C.P.S.
Rotselaar, Belgium) at 37°C in a humidified atmosphere,
as this was shown to enhance chondrogenic differentiation
(data not shown). Chondrogenic media were changed every
2–3 days.
For osteogenic differentiation, ASCs (passage 2) were
seeded at 5000 cells/cm
2 and cultured in monolayer in
osteogenic medium, consisting of normal culture medium
supplemented with 10 mM β-glycerol phosphate, 50 μg/ml
ascorbate-2-phosphate, and 100 ng/ml bone morphogenetic
protein 2 (BMP-2, Peprotech EC, London, UK). Osteogenic
medium was changed twice a week.
(Immuno)histochemistry
(Immuno)histochemistry was performed as described pre-
viously (Oedayrajsingh-Varma et al. 2006). Cell nodules
that formed under chondrogenic culture conditions were
stained with Alcian blue (Sigma-Aldrich, Zwijndrecht, The
Netherlands) at acidic pH for detection of proteoglycans.
For the detection of collagen Type II, staining was
performed with mouse monoclonal antibody II-II6B3
(1:50; Developmental Studies Hybridoma Bank, Iowa,
USA) against human collagen Type II in PBS containing
1% BSA.
Osteogenesis was visualized after 21 days of culture in
osteogenic medium by Von Kossa staining to establish the
formation of a calcified matrix, typical for mature osteo-
blasts. The protocol used was as described previously
(Varma et al. 2007) with only one modification of counter-
418 Cell Tissue Res (2008) 332:415–426staining the cytoplasm of the cells using fast green.
Calcified extracellular matrix was visualized as black spots.
Spectrophotometric ALP activity
Early differentiation of MSCs into immature osteoblasts is
characterized by ALP enzyme activity, with human MSCs
expressing ALP as early as 4 days after induction, and
maximum levels being observed at around 14 days after
induction (Jaiswal et al. 1997). Therefore, cellular ALP
activity was measured after culturing the ASCs in osteo-
genic medium for 14 days. Cells were lysed with distilled
water, and the ALP activity and protein content were
determined. To determine ALP activity, p-nitrophenyl
phosphate (Merck, Darmstadt, Germany) at pH 10.3 was
used as the substrate, as described by Lowry (1955). ALP
activity was expressed as micromole per microgram of
protein in the cell layer. The amount of protein was
determined by using a BCA Protein Assay reagent Kit
(Pierce, Rockford, Ill., USA), and the absorbance was read
at 540 nm with a microplate reader (Biorad Laboratories,
Hercules, Calif., USA).
Real-time polymerase chain reaction
RNA isolation and reverse transcription were performed as
previously described (Oedayrajsingh-Varma et al. 2006).
Real-time polymerase chain reactions (PCR) were per-
formed by using the SYBRGreen reaction kit according to
the manufacturer’s instructions (Roche Diagnostics) in a
LightCycler 480 (Roche Diagnostics). cDNA (approximate-
ly 5 ng) was used in a volume of 20 μl PCR mix
(LightCycler DNA Master Fast Start
plus Kit, Roche Diag-
nostics) containing a final concentration of 0.5 pmol
primers. Relative housekeeping gene expression for 18 S-
rRNA (18 S) and relative target gene expression for
aggrecan (AGG), collagen Type II (COL2B), and collagen
Type X (COL10α1) regarding chondrogenic differentiation,
and for collagen Type I (COL1α), osteopontin (OPN), and
runt-related transcription factor 2 (RUNX-2) regarding
osteogenic differentiation were determined.
Primers (Invitrogen) used for real-time PCR are listed in
Table 2. They were designed by using Clone Manager Suite
software program version 6 (Scientific & Educational
Software, Cary, N.C., USA). The amplified PCR fragment
extended over at least one exon border, based on homology
in conserved domains between human, mouse, rat, dog, and
cow, except for the 18 S gene (encoded by one exon only).
Amplified Col2B PCR products were electrophoresed on a
2% agarose gel and stained with ethidium bromide. For real-
time PCR, the values of relative target gene expression were
normalized to relative 18 S housekeeping gene expression.
Real-time PCR data analysis
With the Light Cycler software (version 4), the crossing
points were assessed and plotted versus the serial dilution
of known concentrations of the standards derived from each
gene by the Fit Points method. PCR efficiency was
calculated by Light Cycler software, and the data were
used only if the calculated PCR efficiency was between
1.85–2.0.
Statistics
Kolmogorov-Smirnov tests were used to determine the
normalcy of measurements and, if appropriate, their
logarithmics. For the evaluation of yield and growth
kinetics, means between two groups in one variable were
compared by using the independent sample two-tailed t-
Table 2 PCR primer sets used for reverse transcription/PCR (18 S 18 S subunit, AGG aggrecan, COL1αI collagen Type I, COL2B collagen Type
II, COL10a1 collagen Type X, OPN osteopontin, RUNX-2 runt-related transcription factor 2)
Gene Primer sets Accession number, product length (bp)
18 S Forward: 5′ GTAACCCGTTGAACCCCATT− 3′ Human, NM_10098, 151 bp
Reverse: 5′ CCATCCAATCGGTAGTAGCG 3′
AGG Forward: 5′CAACTACCCGGCCATCC 3′ Human, NM_001135, 160 bp
Reverse: 5′GATGGCTCTGTAATGGAACAC 3′
COL1αI Forward: 5′ AAGCCGAATTCCTGGTCT 3′ Human, NM_000088, 195 bp
Reverse: 5′ TCCAACGAGATCGAGATCC 3′
COL2B Forward: 5′ AGGGCCAGGATGTCCGGCA 3′ Human, NM_033150, 195 bp
Reverse: 5′ GGGTCCCAGGTTCTCCATCT 3′
COL10a1 Forward: 5′ CACTACCCAACACCAAGACA 3′ Human, NM_000493, 225 bp
Reverse: 5′ CTGGTTTCCCTACAGCTGAT 3′
OPN Forward: 5′ TTCCAAGTAAGTCCAACGAAAG 3′ Human, AF_052124, 181 bp
Reverse: 5′ GTGACCAGTTCATGAGATTCAT 3′
RUNX-2 Forward: 5′ ATGCTTCATTCGCCTCAC 3′ Human, NM_001024630, 156 bp
Reverse: 5′ ACTGCTTGCAGCCTTAAAT 3′
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correlation coefficient, r. For evaluation of gene expression,
a repeated measures analysis of variance was used to
determine significant differences when increasing time-
points in one donor within one variable were compared. If
levels of gene expression were below the detection limit
(0.05), values were set at 10
−2 (or log level at −2). All
statistical tests used a significance level of α=0.05.
Results
Effects of tissue-harvesting site on frequency of ASCs
In a previous study, we demonstrated that the yield of
nucleated cells in the SVF of adipose tissue from different
tissue-harvesting sites was similar (Oedayrajsingh-Varma et
al. 2006). To investigate whether the tissue-harvesting site
affected the frequency of ASCs in the SVF in the present
study, limiting dilution and CFU-F assays were performed.
The outcomes of both types of assays were similar (Fig. 1a,
b). When combined, the SVF of adipose tissue harvested
from the abdomen contained 5.1±1.1% ASCs (mean±
SEM), whereas the percentage of ASCs in the SVF of
adipose tissue harvested from the hip/thigh region was
much lower (1.2±0.7%; Fig. 1c). This difference in ASC
frequency between adipose tissue from the abdomen and
hip/thigh region was significant (P=0.0009).
Effect of tissue-harvesting site on frequency of CFUs
having osteogenic differentiation potential
Parallel to the CFU-F assay (Fig. 1b), CFU-ALP assays
were also performed to determine the percentage of the
CFUs capable of osteogenic differentiation. For adipose
tissue from the abdomen, 54.9±12.1% (mean±SEM) of the
CFUs stained positive for ALP, whereas the CFUs from
adipose tissue of the hip/thigh region displayed an ALP
positivity of 72.8±8.1% (Fig. 2). Apparently, no differences
in osteogenic potential existed between ASCs from the two
tissue-harvesting sites (P=0.43).
Phenotypic characterization and growth kinetics of cultured
ASCs
Cultured ASCs (passages 2 to 4) from abdomen and hip/
thigh regions were phenotypically characterized. ASCs
from both tissue-harvesting sites were demonstrated to be
homogeneous populations staining positive for stem-cell-
associated markers CD34, CD54, CD90, CD105, CD166,
and HLA-ABC, and negative for hematopoietic/leukocytic/
endothelial markers such as CD31, CD45, CD106, CD146,
and HLA-DR (Table 3).
Todeterminegrowthkinetics,thepopulationdoublingtime
of ASCs from passages 2 to 3 was determined. When ASCs
numbers were monitored over time, a cell growing curve was
obtained showing an exponential growing phase, after which
the cells reached confluency (Fig. 3a,b). The mean population
doubling time of the ASCs in the exponential growing phase
was about 2 days when the adipose tissue was harvested
from the abdomen and hip/thigh regions (abdomen: 2.1±0.8;
hip/thigh: 2.3±0.3; mean±SEM; Fig. 3c).
Effect of tissue-harvesting site on osteogenic differentiation
potential of ASCs
Differentiation of cultured ASCs into the osteogenic lineage
was induced by culturing the cells in monolayer in
Fig. 1 Effect of adipose-tissue-harvesting site on the frequency of
adipose-derived stem cells (ASCs) in the stromal vascular fraction
(SVF). After isolation of the SVF from adipose tissue of both tissue-
harvesting sites, the frequency of ASCs in the SVF isolates was
determined by using: (a) a limiting dilution assay (LD) and (b)a
colony-forming unit (CFU) assay (CFU-F), with similar results. When
combined (c), a significant difference was detected in ASC frequency
between adipose tissue harvested from the abdomen and adipose tissue
harvested from the hip/thigh region (P-values: a limiting dilution: P=
0.003, b colony-forming unit: P=0.05, c combined: P=0.0009)
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expression of osteogenically induced ASCs from all donors
tested increased over time, RUNX-2 being up-regulated 18-
fold (P=0.002) and COL1α being up-regulated seven-fold
(P=0.024) after 7 days (Fig. 4a,b). OPN gene expression
was increased after 7 days; however, this increase was not
significant (Fig. 4c). No significant differences were
detected in osteogenic gene expression between ASCs
derived from the abdomen and ASCs derived from the
hip/thigh region, at all three time points tested.
ALP activity in the ASCs was measured after 14 days of
osteogenic stimulation. ASCs cultured in control medium
served as negative controls. ALP activity in the osteogeni-
cally stimulated cells was significantly increased (P=0.047)
compared with that in control cells (Fig. 4d). No statisti-
cally significant difference was apparent in ALP activity
between ASCs derived from abdominal fat and ASCs from
hip/thigh fat. Calcification of the osteogenic matrix was
confirmed by using Von Kossa staining; black spots could
be observed after 3 weeks of osteogenic stimulation of
ASCs from both origins (Fig. 4e: abdomen, Fig. 4f: hip/
thigh). No calcification was seen in ASC cultures expanded
in control medium (Fig. 4g).
Effect of tissue-harvesting site on chondrogenic
differentiation potential of ASCs
The chondrogenic differentiation potential of ASCs was
analyzed after culturing the cells in a micromass in
chondrogenic medium containing TGF-β. Within 24 h of
culture, most of the cells formed nodules (n=7).
PCR-amplified COL2B mRNA expression was detectable
but not quantifiable after 7 days in ASCs from both the
abdomen and hip/thigh region in most but not all donors (n=
5). As shown in Fig. 5a, cells from both tissue-harvesting
sites displayed COL2B mRNA. Under non-chondrogenic
conditions, no COL2B could be detected. AGG and
COL10α1 mRNA expression in all donors tested increased
over time, AGG being up-regulated 2.4-fold (P=0.041) at
day 7 when compared with day 4, and COL10α1 being up-
regulated four-fold (P=0.024) after 7 days (Fig. 5b,c). No
significant differences were detected in chondrogenic gene
expression between ASCs derived from the abdomen and
Fig. 2 Effect of adipose-tissue-
harvesting site on the osteogenic
diffentiation capacity of CFU
from the abdomen or hip/thigh
regions. No significant
difference is apparent in the
CFU-alkaline phosphatase
(CFU-ALP) frequency from the
abdomen and hip/thigh region
when corrected for CFU-fibro-
blast (CFU-F).
Table 3 Surface-marker expression of human cultured ASC at
passages 3–4. Results are expressed as mean fluorescence (MF), with
isotype control <4.25 (− MF<8.5; + 8.5<MF<100; ++
100<MF<1000; +++ MF>1000).
Cell-surface marker Cultured ASC (n=4)
CD29 ++
CD31 –
CD34 +
CD45 –
CD54 ++
CD90 +++
CD105 ++
CD106 –
CD146 –
CD166 +
HLA-ABC ++
HLA-DR –
Fig. 3 Effect of the adipose-tissue-harvesting site on growth kinetics
of ASCs in vitro. a Growth kinetics of ASCs of a representative donor
when adipose tissue was harvested from the abdomen. b Growth
kinetics of ASCs when adipose tissue was harvested from the hip/
thigh region. c Population doubling time was calculated from the
exponential growing phase of the cells. There was no significant
difference in population doubling time of ASCs from the abdomen
and hip/thigh region (P=0.78, independent Student t-test).
Cell Tissue Res (2008) 332:415–426 421ASCs derived from the hip/thigh region, at all three time
points tested.
Alcian blue staining demonstrated proteoglycan deposi-
tion in the ASC nodules from both the hip/thigh region and
abdomen (Fig. 5d). At higher magnification (Fig. 5e), the
ASC nodules resembled cartilage-like tissue, composed of
round cells, surrounded by lacunae and lying in a
proteoglycan-rich extracellular matrix that appeared posi-
tive for collagen Type II by immunostaining (Fig. 5f).
Discussion
In this study, we have investigated whether the yield and
functional characteristics of ASCs are affected by the
adipose tissue-harvesting site, i.e., abdomen and hip/thigh
regions. We have found a difference in the frequency of
ASCs between adipose tissue harvested from the abdomen
and the hip/thigh regions. SVF isolates derived from
abdominal fat contain significantly higher frequencies of
ASCs. When cultured, the growth kinetics and surface-
marker expression of ASCs from both tissue-harvesting sites
are similar. We have detected no differences in osteogenic or
chondrogenic differentiation potential between these cultured
ASCs from the two tissue-harvesting sites.
Adipose tissue is a highly heterogeneous tissue, not only
among individuals, but also when comparing different fat
depots within one individual. Donor-dependent differences
have been demonstrated to exist in (stem) cell yield,
proliferation, and differentiation capacity, probably caused
by differences in age (Hauner and Entenmann 1991; van
Harmelen et al. 2003), BMI (Aust et al. 2004; Hauner et al.
1988; Jaiswal et al. 1997; van de Venter et al. 1994), and
diseases such as osteoarthritis and diabetes (Barry 2003;
Murphy et al. 2002; Ramsay et al. 1995). Donors used in
this study for harvesting adipose tissue were healthy female
Fig. 4 Effect of adipose-tissue-
harvesting site on the osteogenic
differentiation of cultured ASCs
in vitro. a–c RUNX-2 (runt-
related transcription factor 2; P=
0.002), COL1α1 (collagen type
Ia; P=0.024), and OPN (osteo-
pontin; P=0.38) gene expression
was measured after 0, 4, and
7 days (d) of osteogenic induc-
tion, by using quantitative real-
time polymerase chain reaction
(qRT-PCR). No significant dif-
ferences were detected in osteo-
genic gene expression between
ASCs derived from the abdo-
men and ASCs derived from the
hip/thigh region, at all three time
points tested. d ALP activity
was significantly increased after
14 days in the osteogenically
stimulated cells (stim) compared
with that in unstimulated cells
(con; P=0.047). No statistically
significant difference was ap-
parent in ALP activity between
ASCs derived from abdominal
fat and ASCs from hip/thigh fat.
e–g Von Kossa staining of ASCs
from abdomen (e) and hip/thigh
region (f) after 21 days of
culture in osteogenic medium
and in control medium (g),
showing mineralized matrix vis-
ible as black spots.
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from tissue engineering of cartilage will be older or might
suffer from disease, and males will also be affected.
Therefore, future research should include these donor types
to determine whether yields and functional characteristics
are influenced by these variables.
In our donor population, no significant correlation has
been detected between the frequency of ASCs and the age
of the donor (P=0.32, r=0.27) or between the frequency of
ASCs and BMI (P=0.42, r=−0.22; data not shown). These
data are in agreement with other studies that have
demonstrated no correlation between BMI or age and
numbers of ASCs per gram of adipose tissue (Hauner and
Entenmann 1991; van Harmelen et al. 2003). Most
importantly, this means that these variables cannot be
responsible for the difference that we have found between
the frequency of ASCs and the tissue-harvesting site.
In addition to donor-dependent heterogeneity, intra-
individual differences between fat depots have been
demonstrated, e.g., with regard to the metabolic response
of adipose tissue to various hormonal and neurological
stimuli (Guilak et al. 2004; Lacasa et al. 1997; Masuzaki et
al. 1995; Monjo et al. 2003; Rodriguez-Cuenca et al. 2005)
and the cellular composition of the adipose tissue (Peptan et
al. 2006; Prunet-Marcassus et al. 2005). In this study, we
have focused on the intra-individual differences in the yield
and function of ASCs from two fat depots: the abdomen
and the hip/thigh region. We have demonstrated that
adipose tissue derived from the abdomen contains signifi-
cant higher frequencies of stem cells compared with
adipose from the hip/thigh region. Whereas SVF isolates
from the abdomen in this study contain about 5.1% of
ASCs, the frequency of ASCs in SVF from the hip/thigh
region is only 1.2%. Moreover, this 1.2% is the average of a
population in which some donors hardly possess any
adipose-derived stem cells (see spreading ASC frequency
hip/thigh in Fig. 1). Despite this more than four-fold
difference, the frequency of ASCs in adipose tissue from
the hip/thigh region is still much higher compared with the
frequency of MSCs in the bone marrow compartment,
Fig. 5 Effect of the tissue-harvesting site on the chondrogenic
differentiation of cultured ASCs in vitro. a Both abdomen (lane 1)
and hip/thigh region (lane 2) display COL2B mRNA. Under
nonchondrogenic conditions, no COL2B could be detected (lane 3).
b, c Aggrecan (AGG; P=0.041) and collagen 10A (Col10a; P=0.024)
gene expression, respectively, was up-regulated after 7 days (d), as
measured by qRT-PCR. No significant differences were detected in
chondrogenic gene expression between ASCs derived from the
abdomen and ASCs derived from the hip/thigh region, at all three
time points tested. d, f Cartilaginous matrix expression was visualized
in both tissue-harvesting sites by staining proteoglycans (Alcian blue)
and COL2 (Col2-II6B3 antibody), respectively. e At higher magnifi-
cation, the ASC nodules resembled cartilage-like tissue, composed of
spherical cells surrounded by lacunae and lying in a proteoglycan-rich
extracellular matrix.
Cell Tissue Res (2008) 332:415–426 423which is as low as 0.001%–0.01% (Pittenger et al. 2000),
thereby making the hip/thigh region still a much more
attractive stem-cell source for tissue engineering therapies.
What are the implications of these stem-cell frequencies
for clinical practice? We have shown that 0.5–2.0×10
8 SVF
cells can be harvested from 100 g adipose tissue, an amount
that can easily be obtained from a patient (Aust et al. 2004;
De Ugarte et al. 2003; Oedayrajsingh-Varma et al. 2006;
Zuk et al. 2001). With an ASC frequency of 5.1%, the SVF
isolates contain between 2.6–10.2×10
6 stem cells, which is
an amount that appears to be sufficient for cell-based
therapies as compared with the amount of cells used by
others (Erickson et al. 2002; Fan et al. 2006; Williams et al.
2003; Zheng et al. 2006). This implies that time-consuming
culturing and expanding steps of the stem cells can be
avoided. In comparison, a bone marrow transplant of
100 ml contains approximately 6.0×10
8 nucleated cells
(Zuk et al. 2002), of which only 0.001%–0.01% (0.06–
0.006×10
6 cells) are stem cells (Pittenger et al. 2000).
To determine the frequency of CFU capable of differenti-
ating into the osteogenic lineage, a CFU-ALP assay has been
performed on cells from the abdomen and hip/thigh region.
The frequencies of CFU-ALP (±3%) are almost comparable
with those of the CFU-F (Figs. 1b, 2). This is higher than the
value that Mitchell et al. (2006) have found in their
clonogenic assay of freshly isolated stromal cells (±0.5%).
However, they have used a different assay method and
shorter incubation period, and their frequency increases to
the same level (5%) after progressive passaging (Mitchell et
al. 2006).
SVF cells have been cultured up to passage 3 to obtain a
homogeneous population of ASCs as starting material for
differentiation studies toward the chondrogenic lineage.
When comparing the growth kinetics of these cultured ASCs
from the abdomen and hip/thigh region, the cell doubling
time appears to be similar, being approximately 2 days. This
is in accordance with the findings of others who have
compared the replication rate of adipocyte precursor cells
from various tissue-harvesting sites (Hauner et al. 1988;
Pettersson et al. 1985; Roncari et al. 1981; Zuk et al. 2001).
On the other hand, when comparing SVF cells from omental
and subcutaneous fat, van Harmelen et al. (2004)h a v ef o u n d
a difference in cell proliferation rate; however, this may be
explained by differences in methodological approach, since
they use stromal cells instead of cultured ASCs. As we have
shown that different fat depots contain different numbers of
stem cells, these differences in proliferation rate may be
caused by differences in initial stem-cell numbers when
using SVF cells. This is reflected in the finding that, in our
study, SVF cells derived from abdominal fat reach 80%–
90% confluency within 5 days, whereas SVF cells derived
from adipose tissue of the hip/thigh region take more than
9 days to reach 80%–90% confluency when seeded in the
same density (data not shown).
In addition to the determination of growth kinetics, we
have phenotypically characterized the cultured ASCs. The
surface-marker expression profile is in accordance with
those found by others (Mitchell et al. 2006; Schaffler and
Buchler 2007; Varma et al. 2007), making both tissue sites
fully comparable with each other (Tables 1, 3).
The homogeneous ASC population has been induced to
the osteogenic and chondrogenic lineages. Having deter-
mined the osteogenic differentiation capacity of ASCs, we
have shown significant up-regulation of osteogenic gene
expression, ALP activity, and matrix mineralization. Inter-
estingly, although no significant difference has been
detected in ALP activity between ASCs from the abdomen
and hip/thigh regions, ASCs from the hip/thigh region tend
to show higher values of ALP activity after induction. This
might be related to the underlying bone tissue, thereby
implying that the ASCs of the hip/thigh region are less
multipotent and more committed to the osteogenic lineage.
The chondrogenic differentiation capacity of the ASCs
has been demonstrated by the up-regulation of AGG and
COL10α1 gene expression and the production of matrix
proteins. No difference has been detected in the chondro-
genic differentiation potential between ASCs from the
abdomen and hip/thigh regions. However, in the PCR
studies, we have not succeeded in quantifying COL2α and
Col2B mRNA expression for any of the donors tested.
Others have obviously faced the same difficulty when trying
to measure the up-regulation of COL2B genes in MSCs
(Huang et al. 2004; Winter et al. 2003; Zuk et al. 2002).
Although intending to measure collagen Type X mRNA
expression as a hypertrophic and therefore late marker of
chondrogenesis, we have noticed that this mRNA is
expressed earlier than collagen Type II mRNA. This is
surprising, as we would expect stem cells to have to
differentiate into chondrocytes before they can become
hypertrophic. However, this unexpected hierarchy of chon-
drogenic gene expression has also been found by Mwale et
al. (2006). Moreover, both Mwale et al. (2006) and we have
found AGG to be constitutively expressed in MSCs. Because
of this constitutive expression of AGG and the early up-
regulation of COL10α1, Mwale et al. (2006)w a r na g a i n s t
using these molecules as markers for chondrogenesis and
chondrocytic hypertrophy. We think that these genes can
nevertheless be used as markers for differentiation into the
chondrogenic lineage, albeit being exclusively shown as the
quantitative up-regulation of gene expression, and always in
combination with other chondrogenic markers (an awareness
of the possible difference in the function of COL10α1i n
chondrogenesis in adult stem cells when compared with
embryonic stem cells is also necessary).
424 Cell Tissue Res (2008) 332:415–426Our lack of detection of any significant differences in the
osteogenic and chondrogenic differentiation potential when
comparing ASCs from the two tissue-harvesting sites seems
to be in contrast with studies of Hauner and Entenmann
1991) who have found differences in the adipogenic
differentiation potential between SVF cells from abdominal
and femoral adipose tissue. However, since Hauner and
Entenmann 1991) have used fresh SVF cells instead of
culture-passaged ASCs, the variation in differentiation
potential might be attributable to differences in numbers
of ASCs in the SVF isolates of the two regions, as we have
shown in this study. Other factors responsible for the
variation in differentiation potential can be ascribed to other
specific histological characteristics of the adipose tissue at
the anatomical site, such as vascularity and amount of
fibrous tissue (Lennon et al. 2000; Peptan et al. 2006;
Pittenger et al. 2000), and to differences in the regulation of
gene expression (Djian et al. 1983; Peptan et al. 2006;
Pittenger et al. 2000).
We therefore conclude that the yield of ASCs is de-
pendent on the tissue-harvesting site. In planning the optimal
one-stage procedure for the regeneration of cartilage tissue,
factors that can positively influence the outcome of the
operation must be taken into account. In view of this, the
abdomen seems to be preferable to the hip/thigh region for
harvesting ASCs.
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